Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

Mitochondria

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...

ATP Synthase: Mechanism

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Patient cerebral organoids capture Alzheimer's disease proteomic biomarkers and drug targets.

bioRxiv : the preprint server for biology·2026

Same author

Evaluating the causal effect of mitochondrial dysfunction on Alzheimer's disease and Parkinson's disease using polygenic risk scores and Mendelian randomization.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Same author

An aging hallmark, Alzheimer's disease, and <i>APOE</i> nexus.

Journal of Alzheimer's disease : JAD·2026

Same author

Limbic-predominant neuroimaging correlates of plasma p-Tau217 in preclinical and clinical Alzheimer's disease.

Frontiers in aging neuroscience·2026

Same author

Downward bias in the association between APOE and Alzheimer's disease using prevalent and by-proxy disease sampling in the All of Us research program.

BMC medical genomics·2026

Same author

Structural signature of plasma proteins classifies the status of Alzheimer's disease.

Nature aging·2026

Search research articles

Related Experiment Video

Updated: Jul 13, 2026

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models

Published on: June 30, 2023

Treating neurodegeneration by modifying mitochondria: potential solutions to a "complex" problem.

Russell H Swerdlow¹

¹Department of Neurology, University of Virginia School of Medicine, Charlottesville, Virginia 22908, USA. rhs7e@virginia.edu

Antioxidants & Redox Signaling

|August 1, 2007

Summary

Mitochondrial dysfunction is common in brain aging and neurodegenerative diseases, characterized by reduced electron transport chain (ETC) activity and increased reactive oxygen species (ROS). New therapeutic strategies targeting these mitochondrial changes show promise for effective brain aging and neurodegenerative disease treatment.

More Related Videos

Optimized Automated Analysis of Live Neuronal Mitochondria Homeostasis Modulation by Isoform-Specific Retinoic Acid Receptors

Optimized Automated Analysis of Live Neuronal Mitochondria Homeostasis Modulation by Isoform-Specific Retinoic Acid Receptors

Published on: July 28, 2023

Microfluidics-Assisted Selective Depolarization of Axonal Mitochondria

Microfluidics-Assisted Selective Depolarization of Axonal Mitochondria

Published on: August 4, 2022

Related Experiment Videos

Last Updated: Jul 13, 2026

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models

Published on: June 30, 2023

Optimized Automated Analysis of Live Neuronal Mitochondria Homeostasis Modulation by Isoform-Specific Retinoic Acid Receptors

Optimized Automated Analysis of Live Neuronal Mitochondria Homeostasis Modulation by Isoform-Specific Retinoic Acid Receptors

Published on: July 28, 2023

Microfluidics-Assisted Selective Depolarization of Axonal Mitochondria

Microfluidics-Assisted Selective Depolarization of Axonal Mitochondria

Published on: August 4, 2022

Area of Science:

Neuroscience
Mitochondrial Biology
Gerontology

Background:

Mitochondria exhibit altered function in aged brains, including diminished electron transport chain (ETC) enzyme activity, impaired ADP phosphorylation, and elevated reactive oxygen species (ROS) production.
Neurodegenerative diseases share and exacerbate mitochondrial dysfunction observed in normal brain aging.

Purpose of the Study:

To review the role of mitochondrial function and dysfunction in brain aging and neurodegenerative diseases.
To explore novel therapeutic strategies targeting mitochondrial pathways for treating these conditions.

Main Methods:

Literature review of studies on mitochondrial function in aging and neurodegenerative diseases.
Analysis of current and emerging therapeutic approaches targeting mitochondrial dysfunction.

Main Results:

Consistent evidence shows reduced ETC enzyme activities, decreased ADP phosphorylation, and increased ROS in aging and neurodegenerative conditions.
Previous therapeutic attempts targeting mitochondrial pathology have yielded limited clinical benefits.

Conclusions:

A deeper understanding of mitochondrial changes in aging and neurodegeneration highlights potential for more efficacious therapeutic interventions.
Strategies aimed at enhancing ETC capacity, boosting oxidative phosphorylation, or reducing mitochondrial ROS are promising for treating brain aging and neurodegenerative diseases.